Skip to main content

RootPath Announces Presentation and Fireside Chat at Built With Biology 2022

RootPath, a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude, today announced that CEO and Co-Founder, Xi Chen, will present an overview of RootPath’s gene synthesis platform PathFinder DNA Assembly™ and Nano Toothpick™ at the Built With Biology Conference on April 13, 2022 at 12:30 pm PDT in Oakland, California.

Susana Donkor, a research associate at RootPath, will participate in a fireside chat at the Built With Biology Conference on April 12, 2022 at 5:25 PM PDT.

About RootPath

RootPath is a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude. Our Molecular Programming-based DNA fragment assembly technology gives researchers and drug developers unprecedented, equitable access to long synthetic genes and their functional readouts. By applying our technology to mine a patient’s immunome, we create truly personalized T cell therapies for solid tumors. Together, with leading partners, we are exploring new applications across multiple industries. We enable biology at scale.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.86
+0.07 (0.03%)
AAPL  260.58
-3.77 (-1.43%)
AMD  203.37
+3.25 (1.62%)
BAC  52.77
-0.59 (-1.11%)
GOOG  303.56
-0.38 (-0.13%)
META  644.78
+1.56 (0.24%)
MSFT  398.46
-1.14 (-0.29%)
NVDA  187.90
-0.08 (-0.04%)
ORCL  156.54
+0.37 (0.24%)
TSLA  411.71
+0.39 (0.09%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.